Careers
Contact Us

Stories tagged hiv vaccine

Results per Page: 20
  • 5
  • 10
  • 20
  • 50
  • 100
New Red Ribbon Registry

New Red Ribbon Registry

Community Compass - July 12, 2022
Trial of Innovative HIV Vaccine Using mRNA Technology Enrolls First Participant

Trial of Innovative HIV Vaccine Using mRNA Technology Enrolls First Participant

Community Compass - July 12, 2022
Increased support needed for a coordinated global HIV and COVID-19 response

Increased support needed for a coordinated global HIV and COVID-19 response

News Releases - March 23, 2022
Trial of innovative HIV vaccine using mRNA technology enrolls first participant

Trial of innovative HIV vaccine using mRNA technology enrolls first participant

News Releases - March 14, 2022
Mosaico Study Update

Mosaico Study Update

Community Compass - December 01, 2021
Experimental Phase 2B HIV Vaccine Regimen Provides Insufficient Protection in Preventing HIV

Experimental Phase 2B HIV Vaccine Regimen Provides Insufficient Protection in Preventing HIV

News Releases - August 31, 2021
Reflections on communicating hope from the ground up in commemoration of World AIDS Day

Reflections on communicating hope from the ground up in commemoration of World AIDS Day

HVTN News - December 01, 2020
Public statement by the HIV Vaccine Trials Network (HVTN) on COVID-19, March 2020

Public statement by the HIV Vaccine Trials Network (HVTN) on COVID-19, March 2020

News Releases - March 23, 2020
HVTN remains steadfast in the pursuit of a safe and globally effective preventive HIV vaccine

HVTN remains steadfast in the pursuit of a safe and globally effective preventive HIV vaccine

HVTN News - March 20, 2020
Experimental HIV vaccine regimen ineffective in preventing HIV

Experimental HIV vaccine regimen ineffective in preventing HIV

News Releases - February 03, 2020
HVTN study confirms correlates of risk associated with decrease in HIV transmission

HVTN study confirms correlates of risk associated with decrease in HIV transmission

News Releases - October 31, 2019
HVTN study demonstrates anti-HIV antibody responses within 6 weeks of initial HIV vaccination

HVTN study demonstrates anti-HIV antibody responses within 6 weeks of initial HIV vaccination

News Releases - October 01, 2019
Cross clade vaccine induced immune responses found in South Africa from the RV144/Thai HIV Vaccine Regimen

Cross clade vaccine induced immune responses found in South Africa from the RV144/Thai HIV Vaccine Regimen

News Releases - September 18, 2019
HVTN joins new public-private partnership; expands scientific journey for a safe and effective HIV vaccine

HVTN joins new public-private partnership; expands scientific journey for a safe and effective HIV vaccine

News Releases - July 16, 2019
HVTN's large-scale HIV vaccine efficacy trials fully enrolled

HVTN's large-scale HIV vaccine efficacy trials fully enrolled

News Releases - June 21, 2019
Study participants move HIV vaccine clinical trials forward

Study participants move HIV vaccine clinical trials forward

News Releases - December 20, 2018
Moving toward a much needed effective HIV vaccine

Moving toward a much needed effective HIV vaccine

News Releases - July 24, 2018
Proactive planning: the potential benefits of an HIV vaccination campaign - a modeling study

Proactive planning: the potential benefits of an HIV vaccination campaign - a modeling study

News Releases - July 24, 2018
HVTN 100 clinical trial findings advance HIV vaccine research and development

HVTN 100 clinical trial findings advance HIV vaccine research and development

News Releases - June 26, 2018
Investigators assess relationship between substance use and retention in 10 phase 1 preventive HIV vaccine clinical trials

Investigators assess relationship between substance use and retention in 10 phase 1 preventive HIV vaccine clinical trials

News Releases - May 24, 2018

News on HVTN

Read MORE
Fauci visits Fred Hutch, discusses pandemics, vaccines and scientific misinformation
Fauci visits Fred Hutch, discusses pandemics, vaccines and scientific misinformation NIAID director’s determined spirit recognized with honorary Hutch Award August 10, 2022
Test of a new 'germline-targeting' HIV vaccine prepares to launch
Test of a new 'germline-targeting' HIV vaccine prepares to launch Vaccine’s unique protein designed to start process of building powerful antibodies against AIDS virus May 19, 2022
Highlights of Fred Hutch science in 2021
Highlights of Fred Hutch science in 2021 From COVID-19 to cancer, Hutch scientists pursued new ideas to save lives December 20, 2021
World AIDS Day 2021: Let's give the gifts of hope and focus to HIV research
World AIDS Day 2021: Let's give the gifts of hope and focus to HIV research HIV scientific infrastructure paved the way for the world’s COVID-19 response. Now, it’s time to return the favor. December 1, 2021